Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
9,689 Dovepress* 8,442 762+ 1,108 9,204
PubMed Central* 0 485 155 485
Totals 8,442 1,247 1,263 9,689
*Since 24 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar